文献速递认知障碍与谵妄多重用药

痴呆患者中潜在不适当用药的种族与民族差异

Racial and ethnic disparities in potentially inappropriate medication use in patients with dementia.
PubMed 文献 · J Am Geriatr Soc · 2024-08-21

研究基于美国NIA资助的阿尔茨海默病研究中心NACCUDS基线数据,纳入≥60岁痴呆患者,用2019 AGS Beers标准评估潜在不适当用药(PIM)。与白人相比,黑人、西班牙裔和亚裔用药总数更少;亚裔任何PIM风险更低;黑人在苯二氮䓬和抗抑郁药PIM上更低,但抗精神病药、心血管药和骨骼肌松弛药PIM更高。

要点

  • 痴呆患者中PIM使用存在显著种族和民族差异。
  • 黑人患者抗精神病药、心血管药和骨骼肌松弛药PIM风险高于白人。
  • 亚裔患者任何PIM及苯二氮䓬类PIM风险低于白人。

核心结论

  • 在能获得痴呆专家诊疗的研究参与者中,PIM暴露及各类药物PIM存在显著种族和民族差异,提示更大社区中差异可能更宽。

研究设计与样本

  • 数据来自美国NIA资助的阿尔茨海默病研究中心NACCUDS基线访视,纳入≥60岁确诊痴呆的参与者。
  • PIM评估采用2019年美国老年医学会Beers标准。
  • 采用逻辑回归、泊松或负二项回归及广义线性模型估计种族和民族与PIM相关结局的关联。

主要发现

  • 与白人相比,黑人、西班牙裔和亚裔参与者报告的总用药数更少(IRR±SE分别为0.903±0.017、0.875±0.021、0.912±0.041,均p<0.01)。
  • 亚裔参与者暴露于任何PIM的可能性更低(OR±SE=0.619±0.118,p<0.05)。
  • 与白人相比,黑人参与者暴露于苯二氮䓬类PIM(OR±SE=0.609±0.094,p<0.01)和抗抑郁药PIM(OR±SE=0.416±0.103,p<0.001)的可能性更低。
  • 黑人参与者暴露于抗精神病药PIM(OR±SE=1.496±0.204,p<0.01)、心血管药PIM(OR±SE=2.193±0.255,p<0.001)和骨骼肌松弛药PIM(OR±SE=2.977±0.860,p<0.001)的可能性更高。
  • 西班牙裔参与者暴露于骨骼肌松弛药PIM更高且抗胆碱能负担更低;亚裔参与者暴露于苯二氮䓬类PIM更少。

关键数值与推荐

  • PIM定义依据2019 AGS Beers标准。
  • 结局包括任何PIM使用、各药物类别任何PIM、痴呆患者最好避免的任何PIM、总用药数、总PIM数、抗胆碱能负担量表(ACBS)及PIM占总用药比例。

临床怎么用

  • 老年医学科医生在痴呆患者用药审查中应关注种族和民族差异,尤其黑人患者抗精神病药、心血管药和骨骼肌松弛药PIM风险较高。
  • 对亚裔和黑人患者可分别关注苯二氮䓬类和抗抑郁药PIM的较低暴露模式,但需结合个体情况评估。

局限性

  • 研究仅纳入能获得痴呆专家诊疗的研究参与者,结论外推至更大社区需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Racial and ethnic disparities in potentially inappropriate medication (PIM) use among older adults with dementia are unclear. METHODS: Data were drawn from the baseline visits of participants who were ≥60 years old and diagnosed with dementia in the National Alzheimer's Coordinating Center Uniform Data Set (NACCUDS) recruited from National Institute on Aging (NIA)-funded Alzheimer's Disease Research Centers (ADCs) throughout the United States. PIM utilization was evaluated using the 2019 American Geriatrics Society Beers Criteria for PIM Use in Older Adults. We estimated the association between race and ethnicity and the following outcomes and estimation models: (1) any PIM use, any PIM in each drug class, and any PIM best avoided in dementia patients using logistic regression models, (2) total number of medications, total number of PIMs, and anticholinergic burden scale (ACBS) using Poisson or negative binomial regression models, and (3) proportion of total medications that were PIMs using generalized linear models (GLM). RESULTS: Compared to White participants, Black, Hispanic, and Asian participants reported taking fewer total medications (incidence rate ratio [IRR] ± standard error[SE] = 0.903 ± 0.017, 0.875 ± 0.021, and 0.912 ± 0.041, respectively, all p < 0.01). Asian participants were less likely to be exposed to any PIM (odds ratio [OR] ± SE = 0.619 ± 0.118, p < 0.05). Compared to White participants, Black participants were less likely to be exposed to benzodiazepine (OR ± SE = 0.609 ± 0.094, p < 0.01) and antidepressant (OR ± SE = 0.416 ± 0.103, p < 0.001) PIMs, but greater antipsychotic (OR ± SE = 1.496 ± 0.204, p < 0.01), cardiovascular (OR ± SE = 2.193 ± 0.255, p < 0.001), and skeletal muscle relaxant (OR ± SE = 2.977 ± 0.860, p < 0.001) PIMs. Hispanic participants were exposed to greater skeletal muscle relaxant PIMs and had lower anticholinergic burden. Asian participants were exposed to fewer benzodiazepine PIMs. DISCUSSION: Significant racial and ethnic disparities in exposure to PIMs and PIMs by medication category in dementia research participants who have access to dementia experts found in the study suggest that disparities may be wider in the larger community.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Zhu CW, Choi J, Hung W, et al. Racial and ethnic disparities in potentially inappropriate medication use in patients with dementia. J Am Geriatr Soc. 2024. PMID: 39166851. doi:10.1111/jgs.19152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。